Literature DB >> 33786523

Self-Administered Questionnaire to Screen for Polycystic Ovarian Syndrome.

Bronwyn S Bedrick1,2, Ashley M Eskew1,3, Jorge E Chavarro4, Emily S Jungheim5.   

Abstract

Background: Polycystic ovary syndrome (PCOS) is a common yet underdiagnosed endocrinopathy with potentially serious sequelae. A screening questionnaire for PCOS can improve early identification and diagnosis. Objective: The purpose of this study was to test the utility of a self-administered questionnaire to help identify women at risk for PCOS. Study Design: We recruited women ages 18-50 with and without PCOS as defined by modified Rotterdam criteria to complete a self-administered survey of common PCOS signs and symptoms. The survey included questions regarding menstrual cycle characteristics and hyperandrogenism as measured by images from the Ferriman-Gallwey (FG) scoring system, and by report of depilatory practices.
Results: Fifty-one women with PCOS and 50 women without PCOS participated in this study. Many study participants were current users of hormonal contraceptives making it difficult to discern menstrual cycle characteristics. Hirsutism, defined by a modification of the FG score of ≥3 from the upper lip and abdomen based on self-assessments, provided a sensitivity of 76% and specificity of 70%, whereas report of any depilatory practices provided a sensitivity of 71% and specificity of 74%. The combined sensitivity of these measures was 93% with a specificity of 52%. In multivariate logistic regression, women who used depilatory techniques had an adjusted odds ratio (aOR) of PCOS of 6.6 (95% confidence interval [CI] 2.5-17.3, p = 0.0002). Those with obesity had similar aOR of PCOS (aOR 6.7, 95% CI 2.5-17.9, p = 0.0001). Addition of other variables did not improve model fit and the net sensitivity and specificity of these two variables did not improve those of depilatory practices and hirsutism. Conclusions: Self-report of depilatory practices or hirsutism is sensitive for identifying women with PCOS. Given the prevalence of PCOS in reproductive-age women and the potentially serious health sequelae, it would be worthwhile to include questions about terminal hair growth and depilatory practices when providing general medical care to reproductive-age women to determine if further testing and screening for PCOS are indicated. This tool may also be helpful in populations where complete diagnostic evaluation may not be feasible. © Bronwyn S. Bedrick et al., 2020; Published by Mary Ann Liebert, Inc.

Entities:  

Keywords:  depilatory; hyperandrogenism; polycystic ovary syndrome

Year:  2020        PMID: 33786523      PMCID: PMC7785063          DOI: 10.1089/whr.2020.0073

Source DB:  PubMed          Journal:  Womens Health Rep (New Rochelle)        ISSN: 2688-4844


  40 in total

1.  Reanalyzing the modified Ferriman-Gallwey score: is there a simpler method for assessing the extent of hirsutism?

Authors:  Heather Cook; Kathleen Brennan; Ricardo Azziz
Journal:  Fertil Steril       Date:  2011-09-15       Impact factor: 7.329

2.  Delayed Diagnosis and a Lack of Information Associated With Dissatisfaction in Women With Polycystic Ovary Syndrome.

Authors:  Melanie Gibson-Helm; Helena Teede; Andrea Dunaif; Anuja Dokras
Journal:  J Clin Endocrinol Metab       Date:  2017-02-01       Impact factor: 5.958

Review 3.  Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  S S Lim; M J Davies; R J Norman; L J Moran
Journal:  Hum Reprod Update       Date:  2012-07-04       Impact factor: 15.610

4.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.

Authors: 
Journal:  Fertil Steril       Date:  2004-01       Impact factor: 7.329

5.  The prevalence and features of the polycystic ovary syndrome in an unselected population.

Authors:  Ricardo Azziz; Keslie S Woods; Rosario Reyna; Timothy J Key; Eric S Knochenhauer; Bulent O Yildiz
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

6.  Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study.

Authors:  E S Knochenhauer; T J Key; M Kahsar-Miller; W Waggoner; L R Boots; R Azziz
Journal:  J Clin Endocrinol Metab       Date:  1998-09       Impact factor: 5.958

7.  Polycystic Ovary Syndrome Is Associated With Adverse Mental Health and Neurodevelopmental Outcomes.

Authors:  Thomas R Berni; Christopher L Morgan; Ellen R Berni; D Aled Rees
Journal:  J Clin Endocrinol Metab       Date:  2018-06-01       Impact factor: 5.958

Review 8.  Polycystic Ovary Syndrome.

Authors:  Ricardo Azziz
Journal:  Obstet Gynecol       Date:  2018-08       Impact factor: 7.661

9.  Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study.

Authors:  Nathalie Roos; Helle Kieler; Lena Sahlin; Gunvor Ekman-Ordeberg; Henrik Falconer; Olof Stephansson
Journal:  BMJ       Date:  2011-10-13

10.  Diagnosis and management of polycystic ovary syndrome in the UK (2004-2014): a retrospective cohort study.

Authors:  Tao Ding; Gianluca Baio; Paul J Hardiman; Irene Petersen; Cormac Sammon
Journal:  BMJ Open       Date:  2016-07-11       Impact factor: 2.692

View more
  1 in total

Review 1.  Clinical management of pregnancy in women with polycystic ovary syndrome: An expert opinion.

Authors:  Mahnaz Bahri Khomami; Helena J Teede; Anju E Joham; Lisa J Moran; Terhi T Piltonen; Jacqueline A Boyle
Journal:  Clin Endocrinol (Oxf)       Date:  2022-04-05       Impact factor: 3.523

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.